Isoflavones and bone: Animal and human evidence of efficacy

Journal of Musculoskeletal Neuronal Interactions

Volumn 2, Issue 4, 2002, Pages 352-359

  Chen, X ^a   Anderson, John J B ^a  

^a IL   (United States)

Author keywords

Bone; Estrogen receptors; Isoflavones; Osteoporosis

Indexed keywords

ANTIESTROGEN; CYTOKINE; DAIDZEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; GLUCURONIC ACID; GLYCITEIN; GLYCOSIDASE; INTERLEUKIN 6; ISOFLAVONE DERIVATIVE; SULFURIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASIAN; BONE CELL; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE TISSUE; BREAST CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; FOOD INTAKE; FRACTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; RAT; REVIEW; SOYBEAN; UTERUS;

EID: 0036620979     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Bradbury RB, White DE. Oestrogens and related substances in plants. Vitam Horm 1954; 12:207-233.
2. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HS. Potential value of plants as sources of new antifertility agents II. J Pharm Sci 1975; 64:717-754.
3. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 1998; 360:142-148.
4. Adlercreutz H. Human health and phytoestrogens. In: Korach KS (ed) Reproductive and developmental toxicology. Marcel Dekker, New York, USA; 1998:299-371.
5. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994; 42:1666-1673.
6. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342:1209-1210.
7. Uehar M, Arai Y, Watanabe S, Adlercreutz H. Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors 2000; 12:217-225.
8. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129:758S-767S.
9. Miksicek RJ. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 1994; 49:153-160.
10. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45:399-405.
11. Routledge EJ, White R, Parker MG, Sumpter JP. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem 2000; 275:35986-35993.
12. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001; 131:1362S-1375S.
13. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139:4252-4263.
14. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997; 138:4509-4512.
15. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257:88-91.
16. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Shimamoto G, DeRose M, Elliot R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattision W, Campell P, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89:309-319.
17. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93:5925-5930.
18. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18:4608-4618.
19. Jones PS, Parrott E, White IN. Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J Biol Chem 1999; 274:32008-32014.
20. Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000; 130:1675-1681.
21. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-5595.
22. Setchell KD. Absorption and metabolism of soy isoflavones-from food to dietary supplements and adults to infants. J Nutr 2000; 130:654S-655S.
23. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000; 36:27-32.
24. Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998; 12:543-557.
25. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996; 61:629-637.
26. Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exper Biol Med 1998; 217:345-350.
27. Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, Tsuji K. Preventive effects of the plant isoflavones, daidzein and genistein, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 1998; 21:62-66.
28. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 1998; 8:274-281.
29. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998; 68:1364S-1368S.
30. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998; 68:1358S-1363S.
31. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 1999; 140:1893-1900.
32. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun 2000; 274:697-701.
33. Toda T, Uesugi T, Hirai K, Nukaya H, Tsuji K, Ishida H. New 6-O-acyl isoflavone glycosides from soybeans fermented with Bacillus subtilis (natto). I. 6-O-succinylated isoflavone glycosides and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 1999; 22:1193-1201.
34. Picherit C, Chanteranne B, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Barlet JP, Coxam V. Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat. Br J Nutr 2001; 85:307-316.
35. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68:1375S-1379S.
36. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000; 72:844-852.
37. Gallagher JC, Rafferty K, Haynatzka V. Effect of soy protein on bone metabolism. J Nutr 2000; 130:667S [Abstract].
38. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 2001; 46:221-226.
39. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 2000; 11:721-724.
40. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001; 97:109-115.
41. Mei J, Yeung SSC, Kung AWC. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001; 86:5217-5221.
42. 2+ influx in osteoblast-like cells: function of tyrosine kinase. J Cell Biochem 1994; 54:487-493.
43. Kozawa O, Suzuki A, Oiso Y. Tyrosine kinase regulates phospholipase D activation at a point downstream from protein kinase C in osteoblast-like cells. J Cell Biochem 1995; 57:251-255.
44. Chae HJ, Chae SW, Kang JS, Kim DE, Kim HR. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways. Res Commun Mol Pathol Pharmacol 1999; 105:185-199.
45. Sugimoto E, Yamaguchi M. Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 2000; 5:515-520.
46. Sugimoto E, Yamaguchi M. Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem Pharmacol 2000; 59:471-475.
47. Dang Z, Van Bezooijen R, Papapoulos S. Genistein and 17beta-estradiol stimulate osteoblastogenesis, but inhibit adipogenesis. J Bone Miner Res 2000; 15:S495 [Abstract].
48. Sandy J, Davies M, Prime S, Farndale R. Signal pathways that transduce growth factor-stimulated mitogenesis in bone cells. Bone 1998; 23:17-26.
49. Nakanishi H, Yamanouchi K, Gotoh Y, Nagayama M. The association of platelet-derived growth factor (PDGF) receptor tyrosine phosphorylation to mitogenic response of human osteoblastic cells in vitro. Oral Dis 1997; 3:236-242.
50. Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-oestrogen on tissues. Nutr Res Rev 1999; 12:75-116.
51. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58:3833-3838.
52. Yoon HK, Chen K, Baylink DJ, Lau KH. Differential effects of two protein tyrosine kinase inhibitors, tyrphostin and genistein, on human bone cell proliferation as compared with differentiation. Calcif Tissue Int 1998; 63:243-249.
53. Chen XW, Garner SC, Anderson JJB. Effects of 17beta-estradiol (E2) and genistein (GEN) on IL-6 synthesis in relation to expression of estrogen receptors (ER) alpha and beta during differentiation in MC3T3-E1 cells. FASEB J 1999; 13: A911:A911 (Abstract #679.916).
54. Busby MG, Jeffcoat AR, Bloedon LT. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single dose administration to healthy men. Am J Clin Nutr 2001; in press
55. Shutt DA. The effects of plant oestrogens on animal reproduction. Endeavour 1976; 35:110-113.
56. Setchell KD, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, Kramer LW, Dresser BL. Tarr MJ. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987; 93:225-233.
57. Whitten PL, Lewis C, Russell E, Naftolin F. Phytoestrogen influences on the development of behavior and gonadotropin function. Proc Soc Exp Biol Med 1995; 208:82-86.